检索结果 - David C. Dalgarno

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    High-throughput prediction of protein conformational distributions with subsampled AlphaFold2

    High-throughput prediction of protein conformational distributions with subsampled AlphaFold2 由 Gabriel Monteiro da Silva, Jennifer Y. Cui, David C. Dalgarno, George P. Lisi, Brenda M. Rubenstein

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    <sup>1</sup>H NMR studies of calmodulin

    <sup>1</sup>H NMR studies of calmodulin 由 David C. Dalgarno, Rachel E. Klevit, Barry A. Levine, Robert J. P. Williams, Z Dobrowolski, W. Drabikowski

    出版 1984
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Proton Nuclear‐Magnetic‐Resonance Spectroscopy of Myosin Subfragment 1 Isoenzymes

    Proton Nuclear‐Magnetic‐Resonance Spectroscopy of Myosin Subfragment 1 Isoenzymes 由 H. Paul PRINCE, Hylary R. Trayer, Gillian D. Henry, Ian P. Trayer, David C. Dalgarno, Barry A. Levine, Peter D. Cary, Christopher H. Turner

    出版 1981
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance

    Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance 由 Mohammad Azam, Valentina Nardi, William C. Shakespeare, Chester A. Metcalf, Regine S. Bohacek, Yihan Wang, Raji Sundaramoorthi, Piotr Sliz, Darren R. Veach, William G. Bornmann, Bayard Clarkson, David C. Dalgarno, Tomi K. Sawyer, George Q. Daley

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Crizotinib‐Resistant Mutants of EML4‐ALK Identified Through an Accelerated Mutagenesis Screen

    Crizotinib‐Resistant Mutants of EML4‐ALK Identified Through an Accelerated Mutagenesis Screen 由 Sen Zhang, Frank Wang, Jeffrey Keats, Xiaotian Zhu, Yaoyu Ning, Scott Wardwell, Lauren Moran, Qurish K. Mohemmad, Rana Anjum, Yihan Wang, Narayana I. Narasimhan, David C. Dalgarno, William C. Shakespeare, Juan J. Miret, Tim Clackson, Victor M. Rivera

    出版 2011
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  6. 6
    Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML

    Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML 由 Thomas O’Hare, Roy M. Pollock, Eric P. Stoffregen, Jeffrey Keats, Omar Mohammed Abdullah, Erika M. Mosesón, Victor M. Rivera, Hao Tang, Chester A. Metcalf, Regine S. Bohacek, Yihan Wang, Raji Sundaramoorthi, William C. Shakespeare, David C. Dalgarno, Tim Clackson, Tomi K. Sawyer, Michael W. Deininger, Brian J. Druker

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds

    Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds 由 David C. Dalgarno, Thilo Stehle, Surinder S. Narula, P. Schelling, Marie Rose van Schravendijk, Susan Adams, Lawrence Andrade, Jeff Keats, Mary K. Ram, Lei Jin, Trudy H. Grossman, Ian A. MacNeil, Chester A. Metcalf, William C. Shakespeare, Yihan Wang, Terry Keenan, Raji Sundaramoorthi, Regine S. Bohacek, Manfred Weigele, Tomi K. Sawyer

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian Carcinoma

    Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian Carcinoma 由 Liz Y. Han, Charles N. Landen, José G. Treviño, Jyotsnabaran Halder, Yvonne G. Lin, Aparna A. Kamat, Tae‐Jin Kim, William M. Merritt, Robert L. Coleman, David M. Gershenson, William C. Shakespeare, Yihan Wang, Raji Sundaramoorth, Chester A. Metcalf, David C. Dalgarno, Tomi K. Sawyer, Gary E. Gallick, Anil K. Sood

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Mobocertinib (TAK-788): A Targeted Inhibitor of<i>EGFR</i>Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer

    Mobocertinib (TAK-788): A Targeted Inhibitor of<i>EGFR</i>Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer 由 Francois Gonzalvez, Sylvie Vincent, Theresa E. Baker, Alexandra E. Gould, Shuai Li, Scott Wardwell, Sara Nadworny, Yaoyu Ning, Sen Zhang, Wei‐Sheng Huang, Yongbo Hu, Feng Li, Matthew T. Greenfield, Stephan G. Zech, Biplab Das, Narayana I. Narasimhan, Tim Clackson, David C. Dalgarno, William C. Shakespeare, Michael Fitzgerald, Johara Chouitar, Robert Griffin, Shengwu Liu, Kwok‐Kin Wong, Xiaotian Zhu, Victor M. Rivera

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

    AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance 由 Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu, Christopher A. Eide, Victor M. Rivera, Frank Wang, Lauren T. Adrian, Tianjun Zhou, Wei-Sheng Huang, Qihong Xu, Chester A. Metcalf, Jeffrey W. Tyner, Marc Loriaux, Amie S. Corbin, Scott Wardwell, Yaoyu Ning, Jeffrey Keats, Yihan Wang, Raji Sundaramoorthi, Mathew Thomas, Dong Zhou, J. T. Snodgrass, Lois Commodore, Tomi K. Sawyer, David C. Dalgarno, Michael W. Deininger, Brian J. Druker, Tim Clackson

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

    Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity 由 William C. Shakespeare, Michael G. Yang, Regine S. Bohacek, Franklin Cerasoli, Karin J. Stebbins, Raji Sundaramoorthi, Mihai Azimioara, Chi B. Vu, Selvi Pradeepan, Chester A. Metcalf, Chad A. Haraldson, Taylor Merry, David C. Dalgarno, Surinder S. Narula, Marcos Hatada, Xiaode Lu, Marie Rose van Schravendijk, Susan Adams, Shelia M. Violette, Jeremy A. Smith, Wei Guan, Catherine Bartlett, Jay Herson, John D. Iuliucci, Manfred Weigele, Tomi K. Sawyer

    出版 2000
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models

    The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models 由 Sen Zhang, Rana Anjum, Rachel M. Squillace, Sara Nadworny, Tianjun Zhou, Jeff Keats, Yaoyu Ning, Scott Wardwell, David F. Miller, Youngchul Song, Lindsey Eichinger, Lauren Moran, Wei‐Sheng Huang, Shuangying Liu, Dong Zou, Yihan Wang, Qurish K. Mohemmad, Hyun Gyung Jang, Emily Ye, Narayana I. Narasimhan, Frank Wang, Juan J. Miret, Xiaotian Zhu, Tim Clackson, David C. Dalgarno, William C. Shakespeare, Victor M. Rivera

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: